Building a national framework for the establishment of regulatory science for drug development : workshop summary /
"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to ex...
| Автор-организации: | Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. |
|---|---|
| Други автори: | Lebovitz, Yeonwoo., English, Rebecca A., Claiborne, Anne B. |
| Формат: | Електронна книга |
| Език: | English |
| Публикувано: |
Washington, D.C. :
National Academies Press,
℗♭2011.
|
| Предмети: | |
| Онлайн достъп: |
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=359520 |
| Подобни документи: |
Print version::
Building a national framework for the establishment of regulatory science for drug development. |
| Резюме: |
"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description. |
|---|---|
| Физически характеристики: |
1 online resource (xvi, 78 pages) : color illustrations |
| Библиография: |
Includes bibliographical references (pages 53-55). |
| ISBN: |
9780309158909 0309158907 1283019108 9781283019101 |